Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
filingDate |
2001-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2004503582-A |
titleOfInvention |
Anti-tumor combination comprising an aromatase inhibitor and an EGFR antagonist or inhibitor |
abstract |
A method of treating a human suffering from a hormone dependent disorder characterized by overexpression of EGFR, comprising an aromatase inhibitor and an EGFR antagonist or EGFR inhibitor in an amount effective to produce a superadditive or synergistic therapeutic effect. A method comprising administering an agent to said human. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5133071-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10118959-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007091622-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975966-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012255042-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497355-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009122667-A1 |
priorityDate |
2000-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |